
AI Platform for Cytogenetics
Chromosome Analysis & Reporting through Artificial Intelligence Output (CARAIO)
Karyotyping: Training & Decision-Support

Chromosome Analysis & Reporting through Artificial Intelligence Output (CARAIO)
Karyotyping: Training & Decision-Support
CARAIO Technologies has a diverse team of experts in Cytogenetics and Data Science,
and world-class advisors.
Chromosome disorders are genetic conditions that are caused by changes in the number or structure of chromosomes. Down Syndrome is a genetic condition where a person is born with an extra copy of chromosome 21 (Trisomy 21). These disorders can be identified through karyotyping. We provide the digital platform for enabling it.
We use cutting-edge technology to analyze cytogenetic data and provide a platform to facilitate simplified learning and decision making in karyotyping.
We provide AI-based digital platform for efficient, accessible and affordable diagnosis of chromosomal disorders.
Selected by one of the world's top university based startup accelerators as one among the top 60 startups out of more than 1500 applicants worldwide
We are a team of professionals bringing in strong diversified expertise in Technology, Management and Healthcare. We are always welcoming collaborations with relevant organizations and individuals. Interested in learning more about our product and technology? Feel free to connect!
Locations: California, USA and Bangalore, India
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.